These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12097790)

  • 1. Discontinuing paroxetine: a personal account.
    Shoenberger D
    Psychother Psychosom; 2002; 71(4):237-8. PubMed ID: 12097790
    [No Abstract]   [Full Text] [Related]  

  • 2. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 3. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lhermitte's sign in paroxetine withdrawal.
    Reeves RR; Pinkofsky HB
    J Clin Psychopharmacol; 1996 Oct; 16(5):411-2. PubMed ID: 8889917
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinuation symptoms and SSRIs.
    Pollock BG
    J Clin Psychiatry; 1998 Oct; 59(10):535-7. PubMed ID: 9818635
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 10. Discontinuation of antidepressant therapy: emerging complications and their relevance.
    Thompson C
    J Clin Psychiatry; 1998 Oct; 59(10):541-8. PubMed ID: 9818638
    [No Abstract]   [Full Text] [Related]  

  • 11. Palinopsia and paroxetine withdrawal.
    Terao T
    J Clin Psychiatry; 2002 Apr; 63(4):368. PubMed ID: 12000213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paroxetine withdrawal syndrome].
    Belloeuf L; Le Jeunne C; Hugues FC
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A52-3. PubMed ID: 10855379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute dystonia following paroxetine withdrawal].
    Cabo-López I; García-Bermejo P; González-Roiz C; Durán-Martínez P; García-Ruiz PJ
    Rev Neurol; 2008 Feb 16-29; 46(4):253-4. PubMed ID: 18327750
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 16. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine discontinuation syndrome in association with sertindole therapy.
    Walker-Kinnear M; McNaughton S
    Br J Psychiatry; 1997 Apr; 170():389. PubMed ID: 9246265
    [No Abstract]   [Full Text] [Related]  

  • 18. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
    Frost L; Lal S
    Am J Psychiatry; 1995 May; 152(5):810. PubMed ID: 7726327
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SSRI withdrawal.
    Mareth TR; Brown TM
    J Clin Psychiatry; 1996 Jul; 57(7):310. PubMed ID: 8666577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.